Mitochondrial optic neuropathies: our travels from bench to bedside and back again

被引:41
|
作者
Sadun, Alfredo A. [1 ]
La Morgia, Chiara [2 ,3 ]
Carelli, Valerio [1 ,2 ,3 ]
机构
[1] Univ So Calif, Keck Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA
[2] Univ Bologna, Bellaria Hosp, Neurol Unit, IRCCS Ist Sci Neurol, Bologna, Italy
[3] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DiBiNeM, Bologna, Italy
来源
关键词
Leber's hereditary optic neuropathy; mitochondria; optic nerve; ASYMPTOMATIC CARRIERS; IDEBENONE TREATMENT; DNA; MUTATION; DYSFUNCTION; ATROPHY; DEATH; OPA1; NEURODEGENERATION; PEDIGREE;
D O I
10.1111/ceo.12086
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The standard scientific method requires that you make an interesting observation, generate a hypothesis and then design an experiment to test the hypothesis. In ophthalmology, as in most fields of medicine, the observations and hypotheses tend to have more degrees of freedom, and the interpretation of experiments is also more complicated and often indeterminate. But sometimes it works out, going back and forth from bench to bedside to bench, in reiterative cycles. A successful example of alternating bench and bedside studies was presented (AAS) at the 2012 Alper Memorial given at the Washington Hospital Medical Center, illustrating a series of questions and investigations that pertain to mitochondrial optic neuropathies, beginning two decades ago, before the concept of mitochondrial optic neuropathies had much meaning. Basic science questions are often best answered by that extraordinary experiment of nature that we call clinical disease, and clinical questions are often best tested in the laboratory.
引用
收藏
页码:702 / 712
页数:11
相关论文
共 50 条
  • [41] Advances in Radiotherapy Immune Modulation From Bench-to-Bedside and Back Again
    Wang, Charles X.
    Hunt, Jared
    Feinstein, Shera
    Kim, Soo Kyoung
    Monjazeb, Arta M.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (03) : 617 - 629
  • [42] The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again
    Hofman, Paul
    Ayache, Nicholas
    Barbry, Pascal
    Barlaud, Michel
    Bel, Audrey
    Blancou, Philippe
    Checler, Frederic
    Chevillard, Sylvie
    Cristofari, Gael
    Demory, Mathilde
    Esnault, Vincent
    Falandry, Claire
    Gilson, Eric
    Guerin, Olivier
    Glaichenhaus, Nicolas
    Guigay, Joel
    Ilie, Marius
    Mari, Bernard
    Marquette, Charles-Hugo
    Paquis-Flucklinger, Veronique
    Prate, Frederic
    Saintigny, Pierre
    Seitz-Polsky, Barbara
    Skhiri, Taycir
    Van Obberghen-Schilling, Ellen
    Van Obberghen, Emmanuel
    Yvan-Charvet, Laurent
    CANCERS, 2019, 11 (02)
  • [43] Alpha chain disease: From bedside to bench and back again, an exemplary translation
    Matuchansky, Claude
    PRESSE MEDICALE, 2019, 48 (01): : 63 - 67
  • [44] ADAMTS7 in Cardiovascular Disease From Bedside to Bench and Back Again?
    Arroyo, Alicia G.
    Andres, Vicente
    CIRCULATION, 2015, 131 (13) : 1156 - 1159
  • [45] Epileptogenic ion channel mutations: From bedside to bench and, hopefully, back again
    Mantegazza, Massimo
    Rusconi, Raffaella
    Scalmani, Paolo
    Avanzini, Giuliano
    Franceschetti, Silvana
    EPILEPSY RESEARCH, 2010, 92 (01) : 1 - 29
  • [46] Biological basis of critical illness subclasses: from the bedside to the bench and back again
    Stevens, Joseph
    Tezel, Oguzhan
    Bonnefil, Valentina
    Hapstack, Matthew
    Atreya, Mihir R.
    CRITICAL CARE, 2024, 28 (01)
  • [47] Tricyclic antidepressants and their local anesthetic properties: From bench to bedside and back again
    Gerner, P
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2004, 29 (03) : 286 - 289
  • [48] From Bedside to Bench and Back
    Simoncelli, Tania
    ISSUES IN SCIENCE AND TECHNOLOGY, 2023, 39 (04) : 66 - 72
  • [49] From bench to bedside and back?
    Diane Gershon
    Nature, 2001, 411 (6840) : 6 - 6
  • [50] From bench to bedside and back?
    Diane Gershon
    Nature, 2001, 411 (6840) : 4 - 5